REQUEST A DEMO
Total
USD $0.00
Search more companies

Gwo Xi Stem Cell Applied Technology Co., (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gwo Xi Stem Cell Applied Technology Co., Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Gwo Xi Stem Cell Applied Technology Co., is committed to developing stem cell medicines. The company's main products include pharmaceutical-grade stem cell preparation production technology platform, stem cell activation technology (Nigiro-Med®), pharmaceutical-grade stem cell storage services, and clinical cell preparation quality testing services. The company was established in 2004 and is headquartered in Hsinchu County, Taiwan.

Headquarters
8F., No.243, Dong Sec. 1, Guangming 6Th Rd, Zhubei City
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Gwo Xi Stem Cell Applied Technology Co., report to view the information.

Website: http://www.gwoxi.com.tw

Basic Information
Total Employees:
Purchase the Gwo Xi Stem Cell Applied Technology Co., report to view the information.
Outstanding Shares:
Purchase the Gwo Xi Stem Cell Applied Technology Co., report to view the information.
Financial Auditors:
Purchase the Gwo Xi Stem Cell Applied Technology Co., report to view the information.
Incorporation Date:
March 26, 2004
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
5.52%
Purchase this report to view the information.
2.23%
Purchase this report to view the information.
1.76%
Purchase this report to view the information.
1.65%
Purchase this report to view the information.
1.01%
Subsidiaries
啟安國際生醫投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Gwo Xi Stem Cell Applied Technology Co., report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
13.26%
Total operating revenue
13.32%
Operating profit (EBIT)
-5.72%
EBITDA
N/A
Net Profit (Loss) for the Period
-47.89%
Total assets
15.43%
Total equity
45.7%
Operating Profit Margin (ROS)
4%
Net Profit Margin
-14.15%
Return on Equity (ROE)
-0.1%
Debt to Equity Ratio
-22.24%
Quick Ratio
1.83%
Cash Ratio
1.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?